https://cmtconvention.cmtrf.org/sessions/keynote-building-the-drug-discovery-engine-of-the-future-with-ai-empowered-nodal-biology/2026-10-19T18:00:59+00:00https://cmtconvention.cmtrf.org/sessions/thursday-welcome-address/2026-10-19T18:00:59+00:00https://cmtconvention.cmtrf.org/sessions/patient-voices-how-your-scientific-progress-provides-hope/2026-10-19T18:01:00+00:00https://cmtconvention.cmtrf.org/sessions/keynote-address/2026-10-19T18:01:00+00:00https://cmtconvention.cmtrf.org/sessions/patient-day-keynote-the-momentum-found-in-cmt/2026-10-19T18:01:00+00:00https://cmtconvention.cmtrf.org/sessions/unlocking-the-genetic-secrets-of-cmt/2026-10-19T18:01:00+00:00https://cmtconvention.cmtrf.org/sessions/the-basic-pathology-of-cmt-with-dr-keith-fargo-cso-of-the-cmt-research-foundation/2026-10-19T18:01:00+00:00https://cmtconvention.cmtrf.org/sessions/genetic-models-for-cmt/2026-10-19T18:01:01+00:00https://cmtconvention.cmtrf.org/sessions/patient-voices-living-with-cmt/2026-10-19T18:01:01+00:00https://cmtconvention.cmtrf.org/sessions/patient-fireside-chat-life-with-cmt/2026-10-19T18:01:01+00:00https://cmtconvention.cmtrf.org/sessions/updates-from-companies/2026-10-19T18:01:01+00:00https://cmtconvention.cmtrf.org/sessions/understanding-clinical-trials-2/2026-10-19T18:01:01+00:00https://cmtconvention.cmtrf.org/sessions/cmt1a-endgame-with-cmt-research-foundation-board-member-peter-desilva/2026-10-19T18:01:02+00:00https://cmtconvention.cmtrf.org/sessions/targeting-sarm1-and-axon-degeneration-as-a-design-modifying-strategy-for-the-treatment-of-cmt2a/2026-10-19T18:01:02+00:00https://cmtconvention.cmtrf.org/sessions/trpv4-inhibition-in-the-treatment-of-cmt2c/2026-10-19T18:01:02+00:00https://cmtconvention.cmtrf.org/sessions/overview-of-the-cmt-drug-development-pipeline/2026-10-19T18:01:02+00:00https://cmtconvention.cmtrf.org/sessions/what-to-expect-in-a-clinical-trial/2026-10-19T18:01:02+00:00https://cmtconvention.cmtrf.org/sessions/clinical-trial-readiness-what-are-natural-history-studies/2026-10-19T18:01:02+00:00https://cmtconvention.cmtrf.org/sessions/progress-in-academic-basic-in-cmt-research-dr-rob-burgess-the-jackson-laboratory/2026-10-19T18:01:03+00:00https://cmtconvention.cmtrf.org/sessions/targeting-cytosolic-hdac6-inhibition-for-the-treatment-of-cmt-and-beyond/2026-10-19T18:01:03+00:00https://cmtconvention.cmtrf.org/sessions/supporting-translation-of-cmt1a-gene-therapy-through-aav-mediated-silencing-of-pmp22/2026-10-19T18:01:03+00:00https://cmtconvention.cmtrf.org/sessions/challenges-in-drug-development/2026-10-19T18:01:03+00:00https://cmtconvention.cmtrf.org/sessions/how-i-chose-to-participate-in-a-clinical-trial/2026-10-19T18:01:03+00:00https://cmtconvention.cmtrf.org/sessions/breakout-session-cmt-1a-and-1b/2026-10-19T18:01:04+00:00https://cmtconvention.cmtrf.org/sessions/becoming-part-of-the-solution-the-graf-family/2026-10-19T18:01:04+00:00https://cmtconvention.cmtrf.org/sessions/advancing-medicines-for-charcot-marie-tooth-disease/2026-10-19T18:01:04+00:00https://cmtconvention.cmtrf.org/sessions/development-of-gene-replacement-therapy-for-cmt4a-demyelinating-neuropathy/2026-10-19T18:01:04+00:00https://cmtconvention.cmtrf.org/sessions/common-mechanisms-of-disease/2026-10-19T18:01:04+00:00https://cmtconvention.cmtrf.org/sessions/ways-to-be-involved-through-cmtrf/2026-10-19T18:01:04+00:00https://cmtconvention.cmtrf.org/sessions/cmt2a/2026-10-19T18:01:05+00:00https://cmtconvention.cmtrf.org/sessions/research-underway-by-pharmaceutical-companies-with-dr-keith-fargo-cso-of-the-cmtrf/2026-10-19T18:01:05+00:00https://cmtconvention.cmtrf.org/sessions/aav-vector-delivery-strategies-for-peripheral-nerves/2026-10-19T18:01:05+00:00https://cmtconvention.cmtrf.org/sessions/the-development-of-tissue-tropic-aavs-considerations-inside-out/2026-10-19T18:01:05+00:00https://cmtconvention.cmtrf.org/sessions/models-of-cmt/2026-10-19T18:01:06+00:00https://cmtconvention.cmtrf.org/sessions/fda-and-cmt-how-the-fda-thinks-about-cmt-evaluation/2026-10-19T18:01:06+00:00https://cmtconvention.cmtrf.org/sessions/type-x/2026-10-19T18:01:06+00:00https://cmtconvention.cmtrf.org/sessions/therapeutic-approaches-using-gene-therapy-dr-amanda-haidet-philips/2026-10-19T18:01:06+00:00https://cmtconvention.cmtrf.org/sessions/intrathecal-gene-replacement-for-ighmbp2-related-conditions/2026-10-19T18:01:06+00:00https://cmtconvention.cmtrf.org/sessions/developing-lipid-nanoparticles-for-non-liver-rna-delivery/2026-10-19T18:01:06+00:00https://cmtconvention.cmtrf.org/sessions/the-state-of-gene-therapy-in-cmt/2026-10-19T18:01:07+00:00https://cmtconvention.cmtrf.org/sessions/the-rest-of-the-pipeline/2026-10-19T18:01:07+00:00https://cmtconvention.cmtrf.org/sessions/other-types-i-dont-know-my-type/2026-10-19T18:01:07+00:00https://cmtconvention.cmtrf.org/sessions/therapeutic-potential-of-clz-2002-by-remyelination-and-nerve-regeneration-dr-sung-chul-jung/2026-10-19T18:01:07+00:00https://cmtconvention.cmtrf.org/sessions/next-generation-strategies-for-next-generation-schwann-cell-targeting-therapeutics/2026-10-19T18:01:07+00:00https://cmtconvention.cmtrf.org/sessions/current-status-of-clinical-outcome-assessments-and-biomarkers-in-cmt/2026-10-19T18:01:08+00:00https://cmtconvention.cmtrf.org/sessions/clinical-trial-readiness/2026-10-19T18:01:08+00:00https://cmtconvention.cmtrf.org/sessions/the-hope-i-find-in-the-progress-made-in-cmt/2026-10-19T18:01:08+00:00https://cmtconvention.cmtrf.org/sessions/genetic-testing/2026-10-19T18:01:08+00:00https://cmtconvention.cmtrf.org/sessions/questions-and-answers-with-dr-amanda-haidet-philip-dr-sung-chul-and-dr-keith-fargo/2026-10-19T18:01:08+00:00https://cmtconvention.cmtrf.org/sessions/advancing-polymer-nanoparticle-delivery/2026-10-19T18:01:09+00:00https://cmtconvention.cmtrf.org/sessions/understanding-the-criteria-for-pursuing-a-drug-program-for-cmt/2026-10-19T18:01:09+00:00https://cmtconvention.cmtrf.org/sessions/translating-academic-science-to-business/2026-10-19T18:01:09+00:00https://cmtconvention.cmtrf.org/sessions/using-ai-to-build-better-outcome-measurements/2026-10-19T18:01:10+00:00https://cmtconvention.cmtrf.org/sessions/how-can-you-make-an-impact-on-cmt/2026-10-19T18:01:10+00:00https://cmtconvention.cmtrf.org/sessions/preparing-for-clinical-trials-in-cmt-dr-david-herrmann-university-of-rochester/2026-10-19T18:01:10+00:00https://cmtconvention.cmtrf.org/sessions/small-molecule-modulation-of-pmp22-expression-and-trafficking/2026-10-19T18:01:10+00:00https://cmtconvention.cmtrf.org/sessions/discovery-of-small-molecules-that-alter-the-trafficking-of-pmp22-as-a-potential-route/2026-10-19T18:01:11+00:00https://cmtconvention.cmtrf.org/sessions/pushing-boundaries-in-cmt-research-early-stage-biotech-companies-evolution-and-insights-on-therapy/2026-10-19T18:01:11+00:00https://cmtconvention.cmtrf.org/sessions/hearing-and-cmt/2026-10-19T18:01:11+00:00https://cmtconvention.cmtrf.org/sessions/bracing-and-orthotics-what-you-need-to-know/2026-10-19T18:01:11+00:00https://cmtconvention.cmtrf.org/sessions/interventional-trials-present-and-near-future-dr-mario-saporta-university-of-miami/2026-10-19T18:01:12+00:00https://cmtconvention.cmtrf.org/sessions/3d-cellular-model-of-myelination-using-human-induced-pluripotent-stem-cells-to-study-cmt4c/2026-10-19T18:01:12+00:00https://cmtconvention.cmtrf.org/sessions/developing-best-in-class-hdac6-inhibitors-for-the-treatment-of-cmt1a/2026-10-19T18:01:12+00:00https://cmtconvention.cmtrf.org/sessions/2023-convention-sizzle-reel/2026-10-19T18:01:12+00:00https://cmtconvention.cmtrf.org/sessions/the-reason-to-visit-an-inherited-neuropathy-consortium-site/2026-10-19T18:01:13+00:00https://cmtconvention.cmtrf.org/sessions/cmt-clinical-trials-whats-new-and-whats-next/2026-10-19T18:01:13+00:00https://cmtconvention.cmtrf.org/sessions/patients-changing-the-pace-of-clinical-trials-dr-don-wood-ceo-of-muscular-dystrophy-association/2026-10-19T18:01:13+00:00https://cmtconvention.cmtrf.org/sessions/friday-welcome-address/2026-10-19T18:01:13+00:00https://cmtconvention.cmtrf.org/sessions/fda-efforts-to-advance-medical-product-development-for-rare-diseases/2026-10-19T18:01:13+00:00https://cmtconvention.cmtrf.org/sessions/2023-kick-off-session/2026-10-19T18:01:13+00:00https://cmtconvention.cmtrf.org/sessions/the-pros-and-cons-of-genetic-testing/2026-10-19T18:01:14+00:00https://cmtconvention.cmtrf.org/sessions/biopharma-activity-in-cmt/2026-10-19T18:01:14+00:00https://cmtconvention.cmtrf.org/sessions/questions-and-answers-with-drs-wood-herrmann-and-saporta/2026-10-19T18:01:14+00:00https://cmtconvention.cmtrf.org/sessions/pathfinder-award-presentation/2026-10-19T18:01:14+00:00https://cmtconvention.cmtrf.org/sessions/govorestat-for-cmt-sord-designing-a-clinical-trial-for-a-slow-progressing-cmt/2026-10-19T18:01:14+00:00https://cmtconvention.cmtrf.org/sessions/patient-voices/2026-10-19T18:01:15+00:00https://cmtconvention.cmtrf.org/sessions/patient-perspectives-to-inform-therapeutic-development-and-trial-design/2026-10-19T18:01:15+00:00https://cmtconvention.cmtrf.org/sessions/an-overview-of-cmt1a-dr-bruce-carter-vanderbilt-university/2026-10-19T18:01:15+00:00https://cmtconvention.cmtrf.org/sessions/keynote-from-genes-to-treatments-strategic-considerations-for-cmt-therapy-development/2026-10-19T18:01:15+00:00https://cmtconvention.cmtrf.org/sessions/understanding-basic-biological-mechanisms-to-identify-therapeutic-targets-in-cmt/2026-10-19T18:01:15+00:00https://cmtconvention.cmtrf.org/sessions/understanding-the-importance-of-genetic-testing/2026-10-19T18:01:16+00:00https://cmtconvention.cmtrf.org/sessions/humanized-cmt1a-model-with-myelination-defect-for-therapy-development/2026-10-19T18:01:16+00:00https://cmtconvention.cmtrf.org/sessions/breakout-session-for-other-types-of-cmt-dr-brett-mccray-johns-hopkins-university/2026-10-19T18:01:16+00:00https://cmtconvention.cmtrf.org/sessions/clinical-trial-design-for-gene-based-therapies-in-ultra-rare-diseases/2026-10-19T18:01:16+00:00https://cmtconvention.cmtrf.org/sessions/clinical-development-of-clc-inhibitor-for-the-treatment-of-charcot-marie-tooth-disease/2026-10-19T18:01:16+00:00https://cmtconvention.cmtrf.org/sessions/cmt-all-types/2026-10-19T18:01:17+00:00https://cmtconvention.cmtrf.org/sessions/translational-approaches-to-cmt1x/2026-10-19T18:01:17+00:00https://cmtconvention.cmtrf.org/sessions/genetics-of-cmt-one-name-many-diseases-with-shawna-feely-university-of-iowa/2026-10-19T18:01:17+00:00https://cmtconvention.cmtrf.org/sessions/preparing-for-clinical-trials-in-cmt2c-challenges-insights-and-unanswered-questions/2026-10-19T18:01:17+00:00https://cmtconvention.cmtrf.org/sessions/you-are-unstoppable/2026-10-19T18:01:17+00:00https://cmtconvention.cmtrf.org/sessions/impacting-drug-development-for-cmt/2026-10-19T18:01:17+00:00https://cmtconvention.cmtrf.org/sessions/myelin-membrane-protein-interactions/2026-10-19T18:01:18+00:00https://cmtconvention.cmtrf.org/sessions/cmt2c-mutations-in-trpv4-dr-brett-mccray-johns-hopkins-university/2026-10-19T18:01:18+00:00https://cmtconvention.cmtrf.org/sessions/using-wearable-sensors-and-technology-to-assess-individuals-living-with-cmt/2026-10-19T18:01:18+00:00https://cmtconvention.cmtrf.org/sessions/development-of-gene-therapy-for-rare-diseases/2026-10-19T18:01:18+00:00https://cmtconvention.cmtrf.org/sessions/patient-powered-perspectives-biotech-insights-on-cmt-and-collaborating-with-patients/2026-10-19T18:01:18+00:00https://cmtconvention.cmtrf.org/sessions/peripheral-nerve-homeostasis-and-regeneration/2026-10-19T18:01:19+00:00https://cmtconvention.cmtrf.org/sessions/elevating-trnagly-levels-as-a-therapeutic-approach-for-cmt2d/2026-10-19T18:01:19+00:00https://cmtconvention.cmtrf.org/sessions/clinical-development-of-clc-1-inhibitors-for-the-treatment-of-cmt/2026-10-19T18:01:19+00:00https://cmtconvention.cmtrf.org/sessions/taking-you-inside-the-clinical-trial-process-part-i-the-scientific-perspective/2026-10-19T18:01:19+00:00https://cmtconvention.cmtrf.org/sessions/illuminating-the-dark-genome-genomic-technologies-transforming-gene-discovery/2026-10-19T18:01:19+00:00https://cmtconvention.cmtrf.org/sessions/from-bench-to-bedside-the-development-of-a-gene-therapy-for-spinal-muscular-dystrophy/2026-10-19T18:01:20+00:00https://cmtconvention.cmtrf.org/sessions/you-and-the-future-of-clinical-trials-in-cmt/2026-10-19T18:01:20+00:00https://cmtconvention.cmtrf.org/sessions/taking-you-inside-the-clinical-trial-process-part-ii-the-patient-perspective/2026-10-19T18:01:20+00:00https://cmtconvention.cmtrf.org/sessions/global-strategies-to-advance-genomic-medicine/2026-10-19T18:01:20+00:00https://cmtconvention.cmtrf.org/sessions/the-sarm1-axon-degeneration-pathway-the-journey-from-academic-lab-to-small-biotech-to-big-pharma/2026-10-19T18:01:20+00:00https://cmtconvention.cmtrf.org/sessions/a-guide-to-clinical-research-one-familys-journey/2026-10-19T18:01:20+00:00https://cmtconvention.cmtrf.org/sessions/becoming-part-of-the-solution/2026-10-19T18:01:21+00:00https://cmtconvention.cmtrf.org/sessions/customized-crispr-base-editors-to-treat-severe-human-diseases/2026-10-19T18:01:21+00:00https://cmtconvention.cmtrf.org/sessions/a-journey-to-cure-michael-a-parents-journey-to-cure-his-son-and-eradicate-a-rare-disorder/2026-10-19T18:01:21+00:00https://cmtconvention.cmtrf.org/sessions/fueling-progress-with-endgame-the-campaign-to-end-cmt1a/2026-10-19T18:01:21+00:00https://cmtconvention.cmtrf.org/sessions/engineering-aavs-for-schwann-cell-delivery-and-blood-nerve-barrier-diffusion/2026-10-19T18:01:21+00:00https://cmtconvention.cmtrf.org/sessions/long-term-exposure-to-elevated-sorbitol-levels-leads-to-prog-of-neuropathic-symptoms-in-cmt-sord/2026-10-19T18:01:22+00:00https://cmtconvention.cmtrf.org/sessions/lessons-learned-from-sod1-als-clinical-development-opportunities-for-cmt-drug-development/2026-10-19T18:01:22+00:00https://cmtconvention.cmtrf.org/sessions/profiling-neurovascular-cells-for-biomarker-discovery/2026-10-19T18:01:22+00:00https://cmtconvention.cmtrf.org/sessions/immune-cell-infiltration-and-nanoparticle-targeting-in-the-connexin32-knockout-model-of-cmt1x/2026-10-19T18:01:22+00:00https://cmtconvention.cmtrf.org/sessions/the-state-of-drug-development-for-cmt/2026-10-19T18:01:22+00:00https://cmtconvention.cmtrf.org/sessions/patient-derived-pns-organoids-to-model-diverse-cmt1b-phenotypes/2026-10-19T18:01:22+00:00https://cmtconvention.cmtrf.org/sessions/a-novel-therapeutic-pipeline-for-charcot-marie-tooth-disease-type-2a/2026-10-19T18:01:23+00:00https://cmtconvention.cmtrf.org/sessions/living-with-cmt/2026-10-19T18:01:23+00:00https://cmtconvention.cmtrf.org/sessions/overt-and-hidden-hearing-loss-in-cmt/2026-10-19T18:01:23+00:00https://cmtconvention.cmtrf.org/sessions/funding-cmt-research-insight-into-the-current-funding-environment-and-ways-to-overcome-challenges/2026-10-19T18:01:23+00:00https://cmtconvention.cmtrf.org/sessions/what-is-happening-to-my-nerves-and-body/2026-10-19T18:01:23+00:00https://cmtconvention.cmtrf.org/sessions/shared-roads-different-destinations-myelinopathy-as-a-common-thread-between-nf2-and-cmt/2026-10-19T18:01:24+00:00https://cmtconvention.cmtrf.org/sessions/topic-building-a-cmt-guidance-document-for-the-fda/2026-10-19T18:01:24+00:00https://cmtconvention.cmtrf.org/sessions/living-with-cmt-2/2026-10-19T18:01:24+00:00https://cmtconvention.cmtrf.org/sessions/node-a-public-neuropathy-data-portal-for-researchers-without-coding-expertise/2026-10-19T18:01:24+00:00https://cmtconvention.cmtrf.org/sessions/forum-obtaining-patient-perspectives-to-help-inform-therapeutic-development-clinical-trial-design/2026-10-19T18:01:24+00:00https://cmtconvention.cmtrf.org/sessions/unstoppable/2026-10-19T18:01:24+00:00https://cmtconvention.cmtrf.org/sessions/aav-gene-therapy-for-peripheral-neuropathies-progress-challenges-and-the-road-ahead/2026-10-19T18:01:25+00:00https://cmtconvention.cmtrf.org/sessions/patient-experience-opening-remarks/2026-10-19T18:01:25+00:00https://cmtconvention.cmtrf.org/sessions/opening-patients-taking-action/2026-10-19T18:01:25+00:00https://cmtconvention.cmtrf.org/sessions/overcoming-immune-responses-to-aav-vectors/2026-10-19T18:01:25+00:00https://cmtconvention.cmtrf.org/sessions/catalyst-award-presentation/2026-10-19T18:01:25+00:00https://cmtconvention.cmtrf.org/sessions/clinical-safety-and-immunologic-considerations-for-systemic-aav-gene-replacement-in-duchenne/2026-10-19T18:01:25+00:00https://cmtconvention.cmtrf.org/sessions/what-is-cmt/2026-10-19T18:01:26+00:00https://cmtconvention.cmtrf.org/sessions/inherent-foot-deformities-cause-increased-lateral-column-loading-in-cmt/2026-10-19T18:01:26+00:00https://cmtconvention.cmtrf.org/sessions/cmt-type-1-mechanisms-and-planned-interventions/2026-10-19T18:01:26+00:00https://cmtconvention.cmtrf.org/sessions/in-vivo-testing-of-crispr-cas9-gene-therapy-approaches-in-a-mouse-model-of-cmt2e/2026-10-19T18:01:26+00:00https://cmtconvention.cmtrf.org/sessions/drugs-under-development-for-cmt/2026-10-19T18:01:26+00:00https://cmtconvention.cmtrf.org/sessions/is-type-1e-cmt-much-more-common-than-recognized/2026-10-19T18:01:27+00:00https://cmtconvention.cmtrf.org/sessions/owning-your-story-how-and-why-to-share-your-journey-with-cmt/2026-10-19T18:01:27+00:00https://cmtconvention.cmtrf.org/sessions/automated-sciatic-nerve-fascicle-segmentation-in-7t-mri/2026-10-19T18:01:27+00:00https://cmtconvention.cmtrf.org/sessions/current-and-emerging-clinical-trials-for-cmt/2026-10-19T18:01:27+00:00https://cmtconvention.cmtrf.org/sessions/clinical-outcome-measures-and-biomarkers-for-cmt-are-we-ready-for-clinical-trials/2026-10-19T18:01:27+00:00https://cmtconvention.cmtrf.org/sessions/understanding-clinical-trials/2026-10-19T18:01:27+00:00https://cmtconvention.cmtrf.org/sessions/beyond-patient-reported-outcomes-defining-meaningful-clinical-endpoints-in-cmt/2026-10-19T18:01:28+00:00https://cmtconvention.cmtrf.org/sessions/trials-for-cmt-one-womans-experience/2026-10-19T18:01:28+00:00https://cmtconvention.cmtrf.org/sessions/dancer-a-new-patient-partnered-platform-for-clinical-trials-in-cmt/2026-10-19T18:01:28+00:00https://cmtconvention.cmtrf.org/sessions/when-you-are-not-eligible-finding-purpose-and-progress-beyond-clinical-trials/2026-10-19T18:01:28+00:00https://cmtconvention.cmtrf.org/sessions/acquiring-investment-funds-from-vcs/2026-10-19T18:01:28+00:00https://cmtconvention.cmtrf.org/sessions/cmt-progress-fueled-by-you/2026-10-19T18:01:29+00:00https://cmtconvention.cmtrf.org/sessions/using-pmp22-antisense-therapy-to-test-molecular-myelin-architecture-in-cmt1a/2026-10-19T18:01:29+00:00https://cmtconvention.cmtrf.org/sessions/speaking-up-for-cmt-turning-awareness-into-action/2026-10-19T18:01:29+00:00https://cmtconvention.cmtrf.org/sessions/inhibiting-the-integrated-stress-response-to-treat-trna-synthetase-associated-cmt/2026-10-19T18:01:29+00:00https://cmtconvention.cmtrf.org/sessions/the-power-of-participation-contributing-to-research-without-enrolling-in-a-trial/2026-10-19T18:01:29+00:00https://cmtconvention.cmtrf.org/sessions/development-of-rtx-117-an-eif2b-activator-targeting-the-integrated-stress-response/2026-10-19T18:01:29+00:00https://cmtconvention.cmtrf.org/sessions/n-of-1-personalized-therapy-for-cmt2s-from-preclinical-models-to-first-in-human-dosing/2026-10-19T18:01:30+00:00